Skip to main content
Rajendra Apte, MD, Ophthalmology, Saint Louis, MO

RajendraApteMD

Ophthalmology Saint Louis, MO

Retinal Disease

Professor

Dr. Apte is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Apte's full profile

Already have an account?

  • Office

    4901 Forest Park Ave
    Fl 6
    Saint Louis, MO 63108
    Phone+1 314-362-3937
    Fax+1 314-362-3725

Summary

  • Dr. Rajendra Apte is an ophthalmologist in Saint Louis, MO. He is the Paul A. Cibis Distinguished Professor and Vice Chair of Innovation and Translation at Washington University in St. Louis School of Medicine and Barnes Hospital. He received his medical degree from University of Bombay. He did his graduate thesis and residency at Parkland Hospital/UT Southwestern and his vitreoretinal fellowship at Johns Hopkins Wilmer Eye Institute and has been in practice 20 years. He specializes in retinal disease and is experienced in diabetic retinopathy, macular degeneration, retina surgery, vitreoretinal disease, and electrophysiology of vision. He has more than 150 publications and over 5000 citations. He is world renowned as a surgeon, innovator, entrepreneur and scientist.

Education & Training

  • LTMMC
    LTMMCClass of 1992

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2000 - 2026
  • MO State Medical License
    MO State Medical License 2003 - 2026
  • MD State Medical License
    MD State Medical License 2001 - 2004
  • American Board of Ophthalmology Ophthalmology

Publications & Presentations

PubMed

Press Mentions

  • Repurposed Drug May Help Stabilize Vision in Rare Disease
    Repurposed Drug May Help Stabilize Vision in Rare DiseaseJune 17th, 2024
  • No Visual Acuity Benefit with Early Anti-VEGF for Diabetic Retinopathy
    No Visual Acuity Benefit with Early Anti-VEGF for Diabetic RetinopathyFebruary 7th, 2023
  • Stem Cell Advances Might Help Dry Eye Disease, Researchers Say
    Stem Cell Advances Might Help Dry Eye Disease, Researchers SayJanuary 4th, 2023
  • Join now to see all